Advertisement
Advertisement
U.S. markets open in 8 hours 40 minutes
Advertisement
Advertisement
Advertisement
Advertisement

DBV Technologies S.A. (DBVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.4700-0.0400 (-2.65%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Gap Down

Gap Down

Previous Close1.5100
Open1.5200
Bid0.0000 x 900
Ask0.0000 x 900
Day's Range1.4700 - 1.5400
52 Week Range1.3510 - 6.8800
Volume134,785
Avg. Volume695,980
Market Cap172.083M
Beta (5Y Monthly)2.05
PE Ratio (TTM)N/A
EPS (TTM)-1.1260
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.94
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for DBVT

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • DBV Technologies S.A.
    Analyst Report: Johnson & JohnsonJohnson & Johnson is a diversified healthcare company that develops, manufactures and markets products in three primary lines of business: Pharmaceuticals, Medical Devices and Diagnostics, and Consumer Products.
    Rating
    Fair Value
    Economic Moat
    17 hours agoArgus Research
View more
  • GlobeNewswire

    Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

    AMF REGULATED INFORMATIONMontrouge, France, January 21, 2022 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today issued the Half-Year report on its liquidity contract with ODDO BHF. As of December 31, 2021, the following assets appeared on the liquidity account: 153,631 DBV Technologies shares;€ 175,542.33. Upon signing the liquidity contract

  • GuruFocus.com

    First Midwest Bank Trust Division Buys Axsome Therapeutics Inc, PROSHARES TRUST, iShares ...

    Joliet, IL, based Investment company First Midwest Bank Trust Division (Current Portfolio) buys Axsome Therapeutics Inc, PROSHARES TRUST, iShares Russell Mid-Cap ETF, ISHARES TRUST, Aurinia Pharmaceuticals Inc, sells Iovance Biotherapeutics Inc, Consumer Discretionary Select Sector SPDR, AT&T Inc, Avis Budget Group Inc, Cerus Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, First Midwest Bank Trust Division.

  • GuruFocus.com

    Henry James International Management Inc. ...

    Investment company Henry James International Management Inc. (Current Portfolio) buys Alibaba Group Holding, iShares MSCI Emerging Markets ETF, Materialise NV, EPAM Systems Inc, Endava PLC, sells Core Laboratories NV, Betterware de Mexico SAB de CV, Gazprom PJSC, Piedmont Lithium Inc, Cellectis SA during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Henry James International Management Inc..

Advertisement
Advertisement